In vitro effects of antipsychotics on mitochondrial respiration
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Assessment of drug-induced mitochondrial dysfunctions is important in drug development as well as in the understanding of molecular mechanism of therapeutic or adverse effects of drugs. The aim of this study was to investigate the effects of three typical antipsychotics (APs) and seven atypical APs on mitochondrial bioenergetics. The effects of selected APs on citrate synthase, electron transport chain complexes (ETC), and mitochondrial complex I- or complex II-linked respiratory rate were measured using mitochondria isolated from pig brain. Complex I activity was decreased by chlorpromazine, haloperidol, zotepine, aripiprazole, quetiapine, risperidone, and clozapine. Complex II + III was significantly inhibited by zotepine, aripiprazole, quetiapine, and risperidone. Complex IV was inhibited by zotepine, chlorpromazine, and levomepromazine. Mitochondrial respiratory rate was significantly inhibited by all tested APs, except for olanzapine. Typical APs did not exhibit greater efficacy in altering mitochondrial function compared to atypical APs except for complex I inhibition by chlorpromazine and haloperidol. A comparison of the effects of APs on individual respiratory complexes and on the overall mitochondrial respiration has shown that mitochondrial functions may not fully reflect the disruption of complexes of ETC, which indicates AP-induced modulation of other mitochondrial proteins. Due to the complicated processes associated with mitochondrial activity, it is necessary t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60733-3 · Cited by 2,561
Srere, P. A. (1969) · Methods in Enzymology · doi:10.1016/0076-6879(69)13005-0 · Cited by 2,005
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Structures of Metal Sites of Oxidized Bovine Heart Cytochrome c Oxidase at 2.8 Å
Tsukihara, T., Aoyama, H., Yamashita, E., Tomizaki, T., Yamaguchi, H., Shinzawa-Itoh, K., Nakashima, R., Yaono, R., & Yoshikawa, S. (1995) · Science · doi:10.1126/science.7652554 · Cited by 1,415
Complete Structure of the 11-Subunit Bovine Mitochondrial Cytochrome bc 1 Complex
Iwata, S., Lee, J. W., Okada, K., Lee, J. K., Iwata, M., Rasmussen, B., Link, T. A., Ramaswamy, S., & Jap, B. K. (1998) · Science · doi:10.1126/science.281.5373.64 · Cited by 1,253
Biochemical and molecular investigations in respiratory chain deficiencies
Rustin, P., Chretien, D., Bourgeron, T., Gérard, B., Rötig, A., Saudubray, J. M., & Munnich, A. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90055-8 · Cited by 1,243
Cytochrome oxidase: an endogenous metabolic marker for neuronal activity
Wong-Riley, M. T. T. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90165-3 · Cited by 1,238
Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140
Pesta, D., & Gnaiger, E. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-382-0_3 · Cited by 987
Atypical antipsychotics: Mechanism of action
Seeman, P. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700106 · Cited by 899
Crystal Structure of Mitochondrial Respiratory Membrane Protein Complex II
Sun, F., Huo, X., Zhai, Y., Wang, A., Xu, J., Su, D., Bartlam, M., & Rao, Z. (2005) · Cell · doi:10.1016/j.cell.2005.05.025 · Cited by 881
Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death
Glassman, A. H., & Bigger, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1774 · Cited by 822
Trounce, I. A., Kim, Y. L., Jun, A. S., & Wallace, D. C. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)64044-0 · Cited by 746
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
Nasrallah, H. A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002066 · Cited by 714
Hunte, C., Koepke, J., Lange, C., Roßmanith, T., & Michel, H. (2000) · Structure · doi:10.1016/s0969-2126(00)00152-0 · Cited by 580
Atomic structure of the entire mammalian mitochondrial complex I
Fiedorczuk, K., Letts, J. A., Degliesposti, G., Kaszuba, K., Skehel, M., & Sazanov, L. A. (2016) · Nature · doi:10.1038/nature19794 · Cited by 517
Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death
Haddad, P. M., & Anderson, I. M. (2002) · Drugs · doi:10.2165/00003495-200262110-00006 · Cited by 435
Letts, J. A., & Sazanov, L. A. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3460 · Cited by 372
Structure of the membrane domain of respiratory complex I
Efremov, R. G., & Sazanov, L. A. (2011) · Nature · doi:10.1038/nature10330 · Cited by 370
Mitochondrial Respiratory Chain Complexes
Sousa, J. S., D’Imprima, E., & Vonck, J. (2018) · Subcellular Biochemistry · doi:10.1007/978-981-10-7757-9_7 · Cited by 231
Ziprasidone in the Management of Schizophrenia: The QT Interval Issue in Context
Taylor, D. (2003) · CNS Drugs · doi:10.2165/00023210-200317060-00004 · Cited by 230
Maurer, I., Zierz, S., & Möller, H.-J. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00075-x · Cited by 221
Neuroleptic medications inhibit complex I of the electron transport chain
Burkhardt, C., Kelly, J. P., Lim, Y., Filley, C. M., & Parker, W. D. (1993) · Annals of Neurology · doi:10.1002/ana.410330516 · Cited by 219
Human complex I defects in neurodegenerative diseases
Schapira, A. H. V. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00032-2 · Cited by 166
The role of mitochondria in pharmacotoxicology: A reevaluation of an old, newly emerging topic
Scatena, R., Bottoni, P., Botta, G., Martorana, G. E., & Giardina, B. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00314.2006 · Cited by 163
Mammalian Mitochondrial Complex I Structure and Disease-Causing Mutations
Fiedorczuk, K., & Sazanov, L. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.06.006 · Cited by 162
Antipsychotics and QT prolongation
Taylor, D. M. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.02078.x · Cited by 161
New Generation Antipsychotic Drugs and QTc Interval Prolongation
Vieweg, W. V. R. (2003) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v05n0504 · Cited by 116
Tardive Dyskinesia: Possible Involvement of Free Radicals and Treatment With Vitamin E
Elkashef, A. M., & Wyatt, R. J. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033414 · Cited by 115
Involvement of brain cholinergic mechanisms in the action of chlorpromazine
Trabucchi, M., Cheney, D. L., RACAGNI, G., et al. (1974) · Nature · doi:10.1038/249664a0 · Cited by 111
Postmortem studies on mitochondria in schizophrenia
Roberts, R. C. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.056 · Cited by 109
Hroudová, J., & Fišar, Z. (2010) · PubMed · Cited by 106
Self-citationMaurer, I., & Möller, H. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6111-8_40 · Cited by 106
Inhibition of monoamine oxidase activity by cannabinoids
Fišar, Z. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0517-6 · Cited by 105
Self-citationInhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation
Balijepalli, S. Y. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00215-9 · Cited by 97
Maurer, I., & Möller, H. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006872911332 · Cited by 96
Jafari, S., Fernandez, F., & Huang, X. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07590.x · Cited by 91
Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine
Vucicevic, L., Misirkic-Marjanovic, M., Paunovic, V., Kravic-Stevovic, T., Martinovic, T., Ciric, D., Maric, N., Petricevic, S., Harhaji-Trajkovic, L., Bumbasirevic, V., et al. (2014) · Autophagy · doi:10.4161/15548627.2014.984270 · Cited by 89
Oliva, C. R., Zhang, W., Langford, C., Suto, M. J., & Griguer, C. E. (2017) · Oncotarget · doi:10.18632/oncotarget.17247 · Cited by 89
Differential effects of typical and atypical neuroleptics on mitochondrial functionin vitro
Modica-Napolitano, J. S., Lagace, C. J., Brennan, W. A., & Aprille, J. R. (2003) · Archives of Pharmacal Research · doi:10.1007/bf02980205 · Cited by 86
Church, M. K., & Young, K. D. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb09419.x · Cited by 86
(2001) · PubMed · Cited by 85
In vitro inhibition of mitochondrial respiratory rate by antidepressants
Hroudová, J., & Fišar, Z. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.017 · Cited by 85
Self-citationNeuroleptic-Induced Mitochondrial Enzyme Alterations in the Rat Brain
Prince, J. A., Yassin, M. S., & Oreland, L. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36399-2 · Cited by 83
Mitochondrial Respiration in the Platelets of Patients with Alzheimer’s Disease
FiŠar, Z., Hroudová, J., Hansíková, H., Spá|ilová, J., Lelková, P., Wenchich, L., Jirák, R., Zv||ová, M., Zeman, J., Martásek, P., et al. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160314150856 · Cited by 82
Self-citationCasademont, J., Garrabou, G., Miró, Ò., López, S., Pons, A., Bernardo, M., & Cardellach, F. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318054753e · Cited by 81
Catalytic mechanisms of complex II enzymes: A structural perspective
Iverson, T. M. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.09.008 · Cited by 80
Scaini, G., Quevedo, J., Velligan, D. I., Roberts, D. L., Raventós, H., & Walss‐Bass, C. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.01.004 · Cited by 79
Folbergrová, J., Ješina, P., Haugvicová, R., Lisý, V., & Houštěk, J. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.11.011 · Cited by 73
Eftekhari, A., Azarmi, Y., Parvizpur, A., & Eghbal, M. A. (2015) · Xenobiotica · doi:10.3109/00498254.2015.1078522 · Cited by 72
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Fišar, Z., Hroudová, J., & Raboch, J. (2010) · PubMed · Cited by 68
Self-citationComplex I and energy thresholds in the brain
Pathak, R. U., & Davey, G. P. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.05.443 · Cited by 52
Putative neuroprotective pharmacotherapies to target the staged progression of mental illness
Robertson, O. D., Coronado, N. G., Sethi, R., Berk, M., & Dodd, S. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12775 · Cited by 52
Tardive dyskinesia and substrates of energy metabolism in CSF
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.12.1730 · Cited by 51
A Structural Perspective on Mechanism and Function of the Cytochrome bc 1 Complex
Hunte, C., Solmaz, S. R., Pálsdóttir, H., & Wenz, T. (2007) · Springer eBooks · doi:10.1007/400_2007_042 · Cited by 48
Partial agonism and schizophrenia
Bolonna, A. A., & Kerwin, R. W. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.186.1.7 · Cited by 46
Agostinho, F. R., Réus, G. Z., Stringari, R. B., Ribeiro, K. F., Ferraro, A. K., Benedet, J., Rochi, N., Scaini, G., STRECK, E. L., & Quevedo, J. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.10.037 · Cited by 44
Pinna, G., Brödel, O., Eravci, M., Stoltenburg, G., Plueckhan, H., Fuxius, S., MEINHOLD, H., & Baumgartner, A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00414-1 · Cited by 42
Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain
STRECK, E. L., Rezin, G. T., Barbosa, L. M., Assis, L. C., Grandi, E., & Quevedo, J. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0178-2 · Cited by 41
Fišar, Z., Jirák, R., Zvěřová, M., Setnička, V., Habartová, L., Hroudová, J., Vaníčková, Z., & Raboch, J. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.04.003 · Cited by 39
Self-citationMetabolic Syndrome and Antipsychotics: The Role of Mitochondrial Fission/Fusion Imbalance
del Campo, A., Bustos, C., Mascayano, C., Acuña‐Castillo, C., Troncoso, R., & Rojo, L. E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00144 · Cited by 39
Masand, P. S., Culpepper, L., Henderson, D. C., Lee, S., Littrell, K. H., Newcomer, J. W., & Rasgon, N. (2005) · CNS Spectrums · doi:10.1017/s1092852900025499 · Cited by 38
GOFF, D. C. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.815 · Cited by 36
Rice, M. W., Smith, K. L., Roberts, R. C., Pérez‐Costas, E., & Meléndez‐Ferro, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100054 · Cited by 34
Spellmann, I., Reinhard, M. A., Veverka, D., Zill, P., Obermeier, M., Dehning, S., Schennach, R., Müller, N., Möller, H., Riedel, M. J., et al. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0880-8 · Cited by 30
Effect of antipsychotics on mitochondrial bioenergetics of rat ovarian theca cells
Elmorsy, E. M., Al-Ghafari, A. B., Aggour, A. M., et al. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.03.018 · Cited by 28
Kosei, N. O. D. A., Suzuki, A., Okui, M., et al. (1979) · PubMed · Cited by 23
Fišar, Z., Hroudová, J., Singh, N., Kopřivová, A., & Maceckova, D. (2016) · Folia Biologica · doi:10.14712/fb2016062020053 · Cited by 21
Self-citationRisperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug.
Keegan, D. A. (1994) · PubMed · Cited by 16
Pig Brain Mitochondria as a Biological Model for Study of Mitochondrial Respiration
Fišar, Z., & Hroudová, J. (2016) · Folia Biologica · doi:10.14712/fb2016062010015 · Cited by 14
Self-citationEffects of aripiprazole and clozapine on the treatment of glycolytic carbon in PC12 cells
Ota, A., Nakashima, A., Kaneko, Y. S., Mori, K., Nagasaki, H., Takayanagi, T., Itoh, M., Kondo, K., Nagatsu, T., & Ota, M. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0782-2 · Cited by 12
Cell-mediated Side Effects of Psychopharmacological Treatment
Maurer, I., & Volz, H. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300116 · Cited by 10
Fišar, Z., Hroudová, J., Singh, N., et al. (2017) · Indian Journal of Biochemistry and Biophysics · Cited by 7
Self-citation
Cited by
Biological hypotheses, risk factors, and biomarkers of schizophrenia
Fišar, Z. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110626 · Cited by 111
Self-citationMitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder
Scaini, G., Andrews, T., Lima, C. N. D. C., Benevenuto, D., STRECK, E. L., & Quevedo, J. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.12.002 · Cited by 93
Das, S. C., Hjelm, B. E., Rollins, B. L., Sequeira, A., Morgan, L., Omidsalar, A. A., Schatzberg, A. F., Barchas, J. D., Lee, F. S., Myers, R., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02127-1 · Cited by 57
“The decreased DLPFC complex I activity in the presence of medications agrees with previous in-vitro and rodent model reports showing decreased complex I activity induced by antipsychotics [59, 60].”
ResultMitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies
Huang, Y., & Zhou, B. (2023) · Biomedicines · doi:10.3390/biomedicines11051500 · Cited by 45
Second-generation antipsychotics and metabolic syndrome: a role for mitochondria
Mortimer, K. R. H., Katshu, M. Z. U. H., & Chakrabarti, L. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1257460 · Cited by 52
“One study found a range of antipsychotics inhibited respiration through specific complexes (65).”
Background
Metadata
- Authors
- Cikánková, T., Fišar, Z., Bakhouche, Y., Ľupták, M., & Hroudová, J.
- Affiliations
- Charles University (CZ)
- Corresponding author
- Hroudová, Jana
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 2019-05-19
- Volume
- 392
- Issue
- 10
- Pages
- 1209-1223
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- OpenAlex
- W2946350621
- Semantic Scholar
- a9ba236d950fe067d3b1439656645ad01097910b
- Cited by
- 44
- References
- 75
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 12 · 2022: 4 · 2021: 6 · 2020: 3 · 2019: 1
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Grantová Agentura České Republiky (17-07585Y)
- Grantová Agentura, Univerzita Karlova (34119)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- antipsychotic drugs, mitochondrial respiration, mitochondrial dysfunction, respiratory chain complexes, mitochondrial complex I inhibition, complex II inhibition, complex IV inhibition, chlorpromazine, haloperidol, zotepine, aripiprazole, quetiapine, risperidone, clozapine, olanzapine, drug-induced mitochondrial toxicity, citrate synthase
- MeSH terms
- Animals, Brain, Energy Metabolism, Mitochondria, Swine, Antipsychotic Agents, Electron Transport Complex II, Electron Transport Complex I, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.